# UK Food Allergy Diagnosis Treatment Market

> UK Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies) and By Age Group (Children, Adults, Elderly) -Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.72%
- **2024:** $ 92.88 Million
- **2025:** $ 99.12 Million
- **2035:** $ 190 Million
- **Key Players:** Thermo Fisher Scientific (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), Allergan (IE), Bristol-Myers Squibb (US)

**Report ID:** MRFR/MED/51067-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/uk-food-allergy-diagnosis-treatment-market-52828

---

## Market Summary

## **UK Food Allergy Diagnosis and Treatment Market Overview**

As per MRFR analysis, the UK Food Allergy Diagnosis and Treatment Market Size was estimated at 331.2 (USD Million) in 2023. The UK Food Allergy Diagnosis and Treatment Market Industry is expected to grow from 400 (USD Million) in 2024 to 850 (USD Million) by 2035. The UK Food Allergy Diagnosis and Treatment Market CAGR (growth rate) is expected to be around 7.093% during the forecast period (2025 - 2035).

### **Key UK Food Allergy Diagnosis and Treatment Market Trends Highlighted**

There has been a substantial increase in the recognition and diagnosis of food allergies in the UK Food Allergy Diagnosis and Treatment Market, primarily due to the expansion of public health initiatives and educational campaigns. The National Health Service (NHS) has prioritized the identification of food allergies and has enhanced accessibility to allergy clinics.

This has resulted in a rise in the number of diagnoses, which in turn has fueled the demand for effective treatments and management solutions. The necessity for customized dietary solutions is another significant market driver. The development of specialized dietary products and treatments, which appeal specifically to individuals with specific allergies, such as nut or dairy allergies, has been prompted by the increasing prevalence of food allergies among the UK population.

The UK Food Allergy Diagnosis and Treatment Market offers a plethora of opportunities for exploration, particularly in the field of innovative treatments like immunotherapy and biological agents. New therapies that provide long-term relief and potential cures are being developed as research continues to progress. Additionally, technology provides the potential for more personalized care by facilitating the monitoring and management of allergies through mobile applications and telehealth services.

In recent years, there has been a rise in the collaboration between healthcare providers and food manufacturers to develop safer dietary options for individuals with allergies. In response to consumer demand for safer and more inclusive food products, retailers are also broadening their product lines to include allergen-free alternatives.

Furthermore, the growing emphasis on comprehensive strategies that incorporate both medical and dietary interventions to address food allergies is consistent with the broader health and wellness trends in the United Kingdom. This collective approach not only addresses immediate healthcare needs but also aims to enhance the quality of life for those living with food allergies.

Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review**

## **UK Food Allergy Diagnosis and Treatment Market Drivers**

### **Increasing Prevalence of Food Allergies**

The increasing prevalence of food allergies in the UK is a significant driver for the UK Food Allergy Diagnosis and Treatment Market Industry. According to the National Health Service (NHS), food allergies affect an estimated 2% of adults and 5-8% of children. This translates to over 2 million individuals in the UK living with some form of food allergy.

The rise in reported cases indicates a growing need for diagnosis and treatment options, which drives market growth. Additionally, recent studies have shown that the incidence of allergies among children has increased by approximately 50% over the last decade. Organizations like Allergy UK are advocating for more awareness, leading to enhanced demand for specialized diagnostic tools and treatments, thus bolstering the market.

### **Advancements in Diagnostic Technologies**

The rapid advancements in diagnostic technologies significantly propel the UK [Food Allergy Diagnosis and Treatment Market](../../../reports/uk-food-allergy-diagnosis-treatment-market-52828) Industry. Technologies such as molecular diagnostics, skin prick tests, and in vitro tests have improved the accuracy and speed of food allergy diagnoses. The UK government has invested in Research and Development (R&D) initiatives aimed at enhancing healthcare technologies, with funding for projects exceeding 250 million over the last three years.

The British Society for Allergy and Clinical Immunology is also promoting the adoption of innovative diagnostic technologies, which are expected to become increasingly integrated into clinical practice, thereby stimulating market growth.

### **Growing Awareness and Education about Food Allergies**

Enhanced awareness and education initiatives regarding food allergies have contributed to market growth within the UK Food Allergy Diagnosis and Treatment Market Industry. Campaigns led by various health organizations, including the National Institute for Health and Care Excellence (NICE), have emphasized the importance of recognizing food allergies and the need for swift diagnosis and treatment.

Public health data shows that approximately 30% of the general population has an inaccurate perception of food allergies, which can lead to underdiagnosis and undermanagement. As educational efforts continue to improve understanding, more individuals are likely to seek diagnostic services, boosting demand in the market.

## **UK Food Allergy Diagnosis and Treatment Market Segment Insights**

### **Food Allergy Diagnosis and Treatment Market Diagnosis Method Insights**

The UK Food Allergy Diagnosis and Treatment Market is witnessing significant growth, particularly in the Diagnosis Method segment, which is crucial in identifying food allergies effectively among the population. This segment comprises several key methods, with each playing a distinctive role in the diagnostic process.

The Skin Prick Test is commonly favored due to its convenience and speed, allowing healthcare professionals to assess allergic reactions to a variety of food allergens through a simple skin reaction assessment. It is recognized for its ability to provide rapid results, contributing to quick clinical decision-making for patients.

The Blood Test also plays a pivotal role in the Diagnosis Method segment, offering a useful alternative for individuals who may have skin conditions that prevent accurate skin testing. By measuring specific IgE antibodies associated with allergic responses, it allows for a comprehensive look at the individual's allergies.

This method has gained traction due to advancements in technology that enhance accuracy and reliability, addressing constraints faced in traditional testing methods. Oral Food Challenge is another vital component, often viewed as the definitive method for diagnosing food allergies.

This challenging process, where patients consume small amounts of suspected allergens under controlled conditions, helps to clarify ambiguous results from other tests. Its significance lies in the ability to provide conclusive evidence of food allergies, guiding healthcare professionals toward appropriate treatment plans.

Elimination Diets are also essential in the process, focusing on removing suspected allergenic foods from a patient's diet for a set period before gradually reintroducing them. This method helps identify specific food intolerances or allergies through practical testing, providing insights that may not be captured through other diagnostic methodologies.

As the UK government continues to invest in awareness and treatment options for food allergies, the significance of these methods becomes increasingly prominent. Ongoing research and development in allergy testing technologies emphasize the need for effective and efficient diagnostic techniques that cater to the growing number of allergy cases within the UK population.

The increasing prevalence of food allergies is driving demand for accurate testing methods, with each of these Diagnostic Methods contributing uniquely to better healthcare outcomes and improved quality of life for those affected. The market dynamic reflects a progressively informed public, with healthcare professionals advocating for regular screenings and improved diagnostic practices to manage food allergies effectively in a region that faces rising health challenges associated with dietary sensitivities.

Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review**

### **Food Allergy Diagnosis and Treatment Market Treatment Type Insights**

The UK Food Allergy Diagnosis and Treatment Market is shaped significantly by the Treatment Type segment, which comprises various approaches to managing food allergies. Medication plays a crucial role, offering relief from symptoms and improving the quality of life for individuals affected by allergies.

Immunotherapy has gained traction as a promising long-term treatment option, gradually desensitizing patients to specific allergens and addressing the root cause rather than just symptoms. Dietary Management is essential, as it involves strategic planning and education to avoid triggers, helping patients effectively navigate their food choices.

Emergency Treatment Devices, such as epinephrine auto-injectors, are critical for swiftly addressing severe allergic reactions, offering peace of mind to both patients and their caregivers. The increasing prevalence of food allergies in the UK, alongside rising awareness and advancements in treatment options, underscores the importance of these categories in enhancing patient outcomes and driving market growth.

The UK Food Allergy Diagnosis and Treatment Market is evolving, reflecting the need for comprehensive solutions tailored to individual needs, ultimately ensuring better health management for those affected by food allergies.

### **Food Allergy Diagnosis and Treatment Market End User Insights**

The UK Food Allergy Diagnosis and Treatment Market is seeing significant engagement across various end-user categories, where each plays a crucial role in the landscape of food allergy management. Hospitals are often at the forefront, providing specialized services and treatment options, thus demonstrating their importance in addressing acute allergy cases.

Clinics serve a vital function by offering accessible care and follow-up treatment, catering to everyday patient needs, and playing a significant role in early diagnosis. Home care systems are becoming increasingly important, as they allow patients to manage allergies with convenience and support from caregivers, reflecting the growing trend toward personalized healthcare.

Moreover, Pharmaceutical Companies are crucial in the innovation of diagnostic and therapeutic solutions, driving advancements through Research and Development initiatives that enhance efficiency in allergy diagnosis and treatment. Overall, each end-user segment contributes uniquely to shaping the UK Food Allergy Diagnosis and Treatment Market by responding to the varying needs of patients and the healthcare ecosystem, making it a dynamic area ripe with growth opportunities.

### **Food Allergy Diagnosis and Treatment Market Age Group Insights**

The UK Food Allergy Diagnosis and Treatment Market provides insightful segmentation based on Age Group, which is crucial for understanding the unique needs across different demographics. Children represent a significant portion of this market due to the rising incidence of food allergies and the emphasis on early diagnosis and effective management strategies.

This age group often faces challenges with allergies that can affect their growth and quality of life, necessitating specialized treatment options. Adults, while also affected, usually encounter allergies that manifest differently from childhood and may require ongoing management, particularly with lifestyle changes impacting dietary choices.

Meanwhile, the elderly population is increasingly recognizing food allergies as a serious health concern, given their implications on comorbidities and overall health management. These age categories contribute to the overall dynamics of the market as each group has distinct approaches to diagnosis and treatment, facilitating targeted innovations in healthcare solutions.

The aging demographic in the UK, coupled with advancements in diagnostic technology, further accentuates the potential for growth in the UK Food Allergy Diagnosis and Treatment Market. Therefore, understanding these Age Group insights helps stakeholders tailor their strategies effectively to meet the diverse needs within this landscape.

## **UK Food Allergy Diagnosis and Treatment Market Key Players and Competitive Insights**

The UK Food Allergy Diagnosis and Treatment Market has seen significant developments in recent years, reflecting an increasing recognition of food allergies as a crucial public health issue. This market is characterized by numerous players who offer a variety of diagnostic tests and treatment options.

Various stakeholders, including healthcare providers, diagnostic laboratories, and pharmaceutical companies, have been actively involved in catering to the growing demand for effective solutions against food allergies. The competitive landscape is continuously evolving, fueled by innovations in diagnostic technologies and therapeutic advancements, reflecting the complexities and needs associated with allergy management.

Companies are striving to develop more accurate and efficient diagnostic tools while also enhancing treatment protocols to improve patient outcomes. Allergy Therapeutics stands out as a key player within the UK Food Allergy Diagnosis and Treatment Market, leveraging its strong expertise in allergy immunotherapy and a robust product portfolio.

The company focuses on developing vaccines and therapies specifically designed for food allergies, showcasing a commitment to addressing this pressing health concern. Its strengths lie in its extensive research capabilities and a dedicated team that drives innovation in allergy treatments. Allergy Therapeutics has established a solid presence in the UK with a wide network of healthcare providers and partnerships that enhance access to its products.

Additionally, the company’s emphasis on clinical trials and real-world evidence strengthens its credibility and market acceptance, establishing it as a leader in developing effective solutions for food allergies. Quest Diagnostics maintains a significant foothold in the UK Food Allergy Diagnosis and Treatment Market by offering a comprehensive suite of diagnostic solutions tailored to food allergies.

The company specializes in various allergy tests, including blood tests and skin prick tests, which are pivotal in accurate diagnosis and management. Quest Diagnostics is recognized for its extensive laboratory network, enabling efficient testing and quicker turnaround times for results. Within the UK, the company has engaged in strategic collaborations that have reinforced its market position, expanding its reach and enhancing its service offerings.

The focus on quality, coupled with advanced technologies in diagnostics, complements its strengths. Quest Diagnostics continuously seeks opportunities for growth through potential mergers and acquisitions, thereby expanding its capabilities and advancing its offerings in the realm of food allergy diagnosis and treatment in the UK.

### **Key Companies in the UK Food Allergy Diagnosis and Treatment Market Include**

- Allergy Therapeutics
- Quest Diagnostics
- MediKidz
- Roche
- **[Eurofins Scientific](https://www.eurofins.in/food-testing/services/food-allergen-testing/)**
- DBV Technologies
- Nutricia
- Thermo Fisher Scientific
- Schwarz Pharma
- Boehringer Ingelheim
- AbbVie
- Aimmune Therapeutics
- Nestle Health Science
- Danone

## **UK Food Allergy Diagnosis and Treatment Market Industry Developments**

Recent developments in the UK Food Allergy Diagnosis and Treatment Market indicate a growing emphasis on advanced diagnostics and innovative therapeutic solutions. Companies like Allergy Therapeutics and DBV Technologies are at the forefront of Research and Development, focusing on rapidly evolving treatments for food allergies.

In the past few months, there has been increased collaboration among key players, with firms like Quest Diagnostics enhancing their testing capabilities to diagnose allergies more accurately and efficiently. Additionally, Eurofins Scientific has invested significantly in allergy testing technology, reflecting a shift towards personalized medicine in the sector.

In terms of market growth, the valuation of companies like Aimmune Therapeutics and Nestle Health Science has seen a positive upward trend, driven by rising awareness and the prevalence of food allergies in the UK, where it's estimated that about 2% of adults and up to 8% of children suffer from food allergies.

Furthermore, in October 2023, it was announced that AbbVie is working on a merger that could further consolidate its position in the market, aiming to enhance its portfolio in allergy therapeutics. This shift underscores the dynamic nature of the UK Food Allergy Diagnosis and Treatment Market, as strategic partnerships become increasingly common.

## **UK Food Allergy Diagnosis and Treatment Market Segmentation Insights**

### **Food Allergy Diagnosis and Treatment Market Diagnosis Method Outlook**

- Skin Prick Test
- Blood Test
- Oral Food Challenge
- Elimination Diet

### **Food Allergy Diagnosis and Treatment Market Treatment Type Outlook**

- Medication
- Immunotherapy
- Dietary Management
- Emergency Treatment Devices

### **Food Allergy Diagnosis and Treatment Market End User Outlook**

- Hospitals
- Clinics
- Home Care
- Pharmaceutical Companies

### **Food Allergy Diagnosis and Treatment Market Age Group Outlook**

- Children
- Adults
- Elderly

## Market Drivers

### Rising Incidence of Food Allergies

The increasing prevalence of food allergies in the UK is a significant driver for the food allergy-diagnosis-treatment market. Recent studies indicate that approximately 2-3% of adults and 5-8% of children in the UK are affected by food allergies. This rise in incidence necessitates improved diagnostic methods and treatment options, thereby expanding the market. As awareness grows, healthcare providers are more likely to invest in advanced diagnostic tools and therapies, which could lead to a market growth rate of around 10% annually. The heightened demand for effective management solutions for food allergies is likely to propel innovation and investment in this sector.

### Advancements in Diagnostic Technologies

Technological innovations in diagnostic tools are transforming the food allergy-diagnosis-treatment market. The introduction of specific IgE testing and component-resolved diagnostics has enhanced the accuracy of food allergy identification. These advancements allow for more precise and quicker diagnoses, which are crucial for effective treatment. The market for diagnostic devices is projected to grow significantly, with estimates suggesting a value of over £500 million by 2027. As healthcare providers adopt these technologies, the overall efficiency of allergy management improves, leading to better patient outcomes and increased market demand.

### Regulatory Support for Allergy Management

The UK government has been increasingly supportive of initiatives aimed at improving food allergy management. Recent regulatory frameworks have been established to ensure better labeling and safety standards for food products. This regulatory environment is beneficial for the food allergy-diagnosis-treatment market, as it fosters trust among consumers and encourages them to seek necessary medical interventions. The implementation of these regulations is likely to enhance the market landscape, with an anticipated growth in the sector as manufacturers and healthcare providers align with these standards. The market could see an increase in value by approximately £200 million by 2026.

### Growing Awareness and Education Initiatives

There is a notable increase in awareness regarding food allergies among the UK population, driven by educational campaigns and advocacy groups. This heightened awareness is crucial for the food allergy-diagnosis-treatment market, as it encourages individuals to seek diagnosis and treatment. Surveys indicate that nearly 70% of the population is now aware of the symptoms and risks associated with food allergies. Consequently, this awareness is likely to lead to a rise in consultations with healthcare professionals, thereby boosting the demand for diagnostic and treatment services. The market is expected to benefit from this trend, with a projected growth rate of 8% over the next few years.

### Increased Investment in Research and Development

Investment in research and development (R&D) within the food allergy-diagnosis-treatment market is on the rise, driven by both public and private sectors. This investment is crucial for the development of novel therapies and diagnostic methods. Recent funding initiatives have allocated millions of pounds towards understanding food allergies better and creating innovative treatment options. The R&D sector is expected to grow at a rate of 12% annually, reflecting the urgent need for effective solutions. As new products and technologies emerge, they are likely to reshape the market landscape, providing patients with more effective management options.

## Future Outlook

The [Food Allergy Diagnosis Treatment Market](https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562) is projected to grow at a 6.72% CAGR from 2025 to 2035, driven by increasing prevalence and advancements in diagnostic technologies.

**New opportunities:**

- Development of AI-driven diagnostic tools for personalized treatment plans.
- Expansion of telehealth services for remote allergy consultations.
- Investment in allergen-free food product lines to capture niche markets.

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer awareness.

## Segment Insights

### By Diagnosis Method: Skin Prick Test (Largest) vs. Oral Food Challenge (Fastest-Growing)

In the UK food allergy-diagnosis-treatment market, the Skin Prick Test remains the largest segment due to its widespread acceptance and ease of administration. This method holds a significant market share compared to Blood Tests and Elimination Diets, reflecting trust among healthcare providers and patients alike. Oral Food Challenges, although less utilized, are gaining traction as healthcare professionals seek conclusive assessments for food allergies, thus increasing their market presence.

Growth trends indicate a rising preference for more refined testing methods, driven by the need for accurate diagnosis in a growing population of allergy sufferers. The increased awareness of food allergies is also fueling demand for diversified testing methods which are perceived as more comprehensive or reliable. As practitioners emphasize accurate diagnosis, segments like Oral Food Challenges are expected to experience rapid growth, transitioning from emerging to mainstream methods in clinical practice.

Skin Prick Test: Dominant vs. Oral Food Challenge: Emerging

The Skin Prick Test is characterized by its non-invasive nature and immediate results, making it a popular choice for initial allergy assessments. It serves effectively in identifying a range of food allergens and fits well within standard clinical protocols. Conversely, the Oral Food Challenge is emerging as a crucial method due to its ability to confirm allergies through actual food consumption under supervised medical conditions. This method is gradually recognized for its role in determining tolerance levels and providing definitive diagnoses, addressing the demand for more conclusive results beyond traditional testing methods.

### By Treatment Type: Medication (Largest) vs. Immunotherapy (Fastest-Growing)

In the UK food allergy-diagnosis-treatment market, the treatment type segment showcases diverse strategies for allergy management. Medication currently holds the largest market share, driven by the widespread availability and acceptance of antihistamines and corticosteroids among consumers. Immunotherapy, while not as large in share as medication, is witnessing rapid adoption due to growing evidence supporting its efficacy and a rising awareness among health practitioners and patients.

The growth trends within this segment indicate a significant shift towards more innovative treatment modalities. Emerging technologies and research in immunotherapy are anticipated to propel this segment, appealing particularly to patients seeking long-term relief from allergies. The increasing prevalence of food allergies is further fueling demand for effective dietary management strategies, emergency treatment devices, and personalized medication, ensuring that this market remains dynamic and competitive.

Medication (Dominant) vs. Immunotherapy (Emerging)

Medication, being the dominant treatment type in the UK food allergy-diagnosis-treatment market, includes established therapies like antihistamines and corticosteroids, which are effective for immediate symptom relief. Its broad accessibility and consumer familiarity make it a go-to option for many patients. In contrast, immunotherapy represents an emerging trend, with therapies such as sublingual and injectable immunotherapy becoming increasingly sought after. Although still in growth phases, the rising clinical evidence supporting immunotherapy paired with awareness campaigns by healthcare providers is escalating its market penetration. Both treatment types serve unique roles; medication focuses on symptom management, while immunotherapy aims for long-term allergy desensitization, catering to different patient needs.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

The distribution of the end user segment in the UK food allergy-diagnosis-treatment market reveals that hospitals dominate with a significant share of the overall market. Hospitals account for the largest portion due to their comprehensive services and access to advanced diagnostic tools. Clinics, while having a smaller share, are rapidly gaining traction, driven by an increase in outpatient services and a growing number of health-conscious individuals seeking allergy testing and treatment in more accessible settings.

Growth trends in this segment are influenced by rising consumer awareness about food allergies and advancements in diagnostic technologies. The increasing prevalence of food allergies among the population, especially among children, is driving demand for effective diagnosis and treatment, primarily in hospitals. Clinics are emerging as a convenient alternative, capturing a faster growth rate as they offer tailored services that meet the needs of patients looking for prompt diagnostic solutions in a less formal environment.

Hospitals: Dominant vs. Clinics: Emerging

Hospitals play a dominant role in the UK food allergy-diagnosis-treatment market due to their extensive resources, availability of specialized healthcare professionals, and the capacity to manage complex cases. They provide comprehensive diagnostic and treatment services, gaining the trust of patients who require thorough evaluations. On the other hand, clinics are an emerging segment that caters to the growing need for allergy assessments in a more immediate and focused manner. They often provide quicker access to testing and treatment protocols, attracting a demographic that prioritizes convenience and personalized care. With the synergy between these two segments, the overall market is set for significant development driven by diverse patient needs.

### By Age Group: Children (Largest) vs. Adults (Fastest-Growing)

In the UK food allergy-diagnosis-treatment market, the age group segment showcases a varied distribution of market share among its key constituents: Children, Adults, and the Elderly. The Children segment holds the largest share, primarily due to the rising awareness around food allergies in early childhood and the increased incidence rates of conditions such as peanut and egg allergies. Adults represent a significant portion as well, but their share is growing at a faster pace driven by changing dietary patterns and increased reporting of food allergies in this demographic.

Looking at growth trends, Adults are witnessing the most rapid growth within the UK food allergy-diagnosis-treatment market. Several drivers contribute to this trend, including greater access to healthcare information, targeted screenings, and the growing recognition of food allergies as a serious health concern. Additionally, the rise in adult onset allergies, coupled with lifestyle changes and dietary preferences, particularly in urban areas, is leading to heightened demand for diagnosis and treatment options.

Children: Dominant vs. Adults: Emerging

The Children segment remains dominant in the food allergy-diagnosis-treatment market, characterized by unique challenges such as issues of effective diagnosis through commonly used tests and the management of treatment protocols tailored to a young audience. This segment benefits from extensive resources allocated to pediatric health, geared towards understanding and addressing food allergies. Additionally, Parents show high engagement in monitoring and preventing allergies in their children, directly impacting their healthcare choices. In contrast, the Adults segment is emerging, spurred by increasing awareness and advocacy for adult food allergies, previously overlooked in favor of pediatric cases. Adults often face complex allergies that may have developed later in life, necessitating different diagnostic and treatment strategies, thus shaping a distinct, rapidly evolving market landscape.

## Competitive Benchmarking

The[food allergy-diagnosis-treatment](https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562)market is characterized by a dynamic competitive landscape, driven by increasing prevalence of food allergies and a growing demand for effective diagnostic and therapeutic solutions. Key players such as Thermo Fisher Scientific (US), Danone (FR), and Aimmune Therapeutics (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Thermo Fisher Scientific (US) focuses on developing advanced diagnostic tools, while Danone (FR) emphasizes nutritional solutions tailored for individuals with food allergies. Aimmune Therapeutics (US) is dedicated to immunotherapy advancements, indicating a trend towards personalized treatment options that collectively shape a competitive environment focused on innovation and patient-centric solutions.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several key players exerting influence through strategic collaborations and product diversification. This fragmentation allows for a variety of approaches to addressing food allergies, fostering a competitive atmosphere that encourages innovation and responsiveness to consumer needs.
In October 2025, Aimmune Therapeutics (US) announced a partnership with a leading UK-based research institution to advance its clinical trials for peanut allergy treatments. This collaboration is significant as it not only enhances Aimmune's research capabilities but also positions the company to tap into the UK market more effectively, potentially accelerating the development of its therapies. Such strategic alliances are crucial in a market where rapid advancements in research can lead to competitive advantages.
In September 2025, Danone (FR) launched a new line of allergen-free products aimed at children, reflecting a growing consumer demand for safe dietary options. This initiative underscores Danone's commitment to addressing food allergies through innovative product development, which may enhance brand loyalty and market share. The introduction of allergen-free products aligns with broader trends towards health-conscious consumerism, positioning Danone favorably in a competitive landscape.
In August 2025, Thermo Fisher Scientific (US) expanded its diagnostic portfolio by acquiring a UK-based biotech firm specializing in food allergy testing. This acquisition is indicative of Thermo Fisher's strategy to enhance its technological capabilities and broaden its service offerings. By integrating advanced testing solutions, the company is likely to strengthen its market position and respond more effectively to the growing demand for precise diagnostic tools.
As of November 2025, current competitive trends in the food allergy-diagnosis-treatment market include a pronounced focus on digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and diagnostics. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition towards a focus on innovation, technology, and supply chain reliability. This transition may redefine market dynamics, emphasizing the importance of developing unique, effective solutions that cater to the specific needs of consumers.

## Recent News & Developments

Recent developments in the UK Food Allergy Diagnosis and Treatment Market indicate a growing emphasis on advanced diagnostics and innovative therapeutic solutions. Companies like Allergy Therapeutics and DBV Technologies are at the forefront of Research and Development, focusing on rapidly evolving treatments for food allergies.

In the past few months, there has been increased collaboration among key players, with firms like Quest Diagnostics enhancing their testing capabilities to diagnose allergies more accurately and efficiently. Additionally, Eurofins Scientific has invested significantly in allergy testing technology, reflecting a shift towards personalized medicine in the sector.

In terms of market growth, the valuation of companies like Aimmune Therapeutics and Nestle Health Science has seen a positive upward trend, driven by rising awareness and the prevalence of food allergies in the UK, where it's estimated that about 2% of adults and up to 8% of children suffer from food allergies.

Furthermore, in October 2023, it was announced that AbbVie is working on a merger that could further consolidate its position in the market, aiming to enhance its portfolio in allergy therapeutics. This shift underscores the dynamic nature of the UK Food Allergy Diagnosis and Treatment Market, as strategic partnerships become increasingly common.

## Report Scope

| MARKET SIZE 2024 | 92.88(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 99.12(USD Million) |
| MARKET SIZE 2035 | 190.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.72% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Thermo Fisher Scientific (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Bayer AG (DE), Mylan N.V. (US), Aimmune Therapeutics (US), Allergan (IE), Bristol-Myers Squibb (US) |
| Segments Covered | Diagnosis Method, Treatment Type, End User, Age Group |
| Key Market Opportunities | Advancements in personalized medicine enhance food allergy-diagnosis-treatment market potential through tailored therapeutic approaches. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative food allergy diagnosis and treatment solutions in the UK. |
| Countries Covered | UK |

## Frequently Asked Questions

**Q: What is the current market valuation of the UK food allergy-diagnosis-treatment market?**
A: The market valuation was $92.88 Million in 2024.

**Q: What is the projected market valuation for the UK food allergy-diagnosis-treatment market by 2035?**
A: The market is expected to reach $190.0 Million by 2035.

**Q: What is the expected CAGR for the UK food allergy-diagnosis-treatment market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.72% during the forecast period.

**Q: Which companies are considered key players in the UK food allergy-diagnosis-treatment market?**
A: Key players include Thermo Fisher Scientific, Danone, Nestle, Abbott Laboratories, Bayer AG, Mylan N.V., Aimmune Therapeutics, Allergan, and Bristol-Myers Squibb.

**Q: What are the main diagnosis methods used in the UK food allergy-diagnosis-treatment market?**
A: Main diagnosis methods include Skin Prick Test, Blood Test, Oral Food Challenge, and Elimination Diet.

**Q: What was the valuation of the Blood Test segment in the UK food allergy-diagnosis-treatment market in 2024?**
A: The Blood Test segment was valued at $30.0 Million in 2024.

**Q: What treatment types are available in the UK food allergy-diagnosis-treatment market?**
A: Available treatment types include Medication, Immunotherapy, Dietary Management, and Emergency Treatment Devices.

**Q: What was the market valuation for the Emergency Treatment Devices segment in 2024?**
A: The Emergency Treatment Devices segment was valued at $17.88 Million in 2024.

**Q: Which age group represents the largest segment in the UK food allergy-diagnosis-treatment market?**
A: The Adults age group represents the largest segment, with a valuation of $40.0 Million in 2024.

**Q: What is the projected growth trend for the Home Care segment in the UK food allergy-diagnosis-treatment market?**
A: The Home Care segment is expected to grow, with a valuation of $20.0 Million in 2024, indicating potential for expansion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-food-allergy-diagnosis-treatment-market-52828*